X

Kobo Biotech Ltd Stock Analysis

Small Cap
Evaluated by 159 users | BSE: 531541 | NSE: |
Pharmaceuticals & Drugs
AVON Organics Limited (AOL) was started by P R Agarwal, Rajesh Agarwal along with late G S Sidhu .It is located at Madhupala Towers Greenlands, Hyderabad 500 016, India. The company's transition from a machinery manufacturer to a full-fledged chemical manufacturer saw the company foraying...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 9.58%9.95%12.51%10.28%-11.08%-12.69%-4.47%-5.22%-7.5%-7.86%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 15016216717056.929.132.5000
Y-o-Y Gr. Rt.-7.8%3%1.9%-66.6%-48.9%12%-100%NANA
Adjusted EPS (Rs.) 3.974.384.473.68-15.25-14.38-7.21-8.04-10.06-10
Y-o-Y Gr. Rt.-10.3%2.1%-17.7%-514.4%NANANANANA
Book Value per Share (Rs.) 24.0827.330.6134.2919.816.080.17-7.8-17.84-28.11
Adjusted Net Profit 8.99.910.18.3-34.3-32.4-17.1-19.2-24-23.8
Net Op. Cash Flow (Rs. Cr.) 16.627.257.638.41119.35.632.331.521
Debt to Cash Flow from Ops 8.494.822.053.4212.437.3727.176.437.0511.28
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Kobo Biotech Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -100%-100%-100%NA
Adjusted EPS -210.8%NANANA
Book Value per Share -201.7-207.3-648.90
Share Price -18.7% -30.3% -29.3% 67.5%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 17.4917.0615.4511.33-56.4-111.13-170.23315.3178.4743.52
Operating Profit Margin (%) 17.4118.0224.8621.01-12.22-34.1811.93000
Net Profit Margin (%) 5.936.086.034.86-60.33-111.39-52.56000
Debt to Equity 2.62.141.711.73.0710.42384.13-11.17-5.22-3.53
Working Capital Days 3193012752819881,8751,675000
Cash Conversion Cycle 1701551381666411,235711000
Entity Percentage Holding
Promoters 44.95%
Institutions 0.66%
Non-Institutions 54.39%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Kobo Biotech Ltd's performance infers:

Kobo Biotech Ltd earnings have grown by 0%, whereas share price has depreciated -30.3% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Kobo Biotech Ltd share prices over the last 10 years. Here is what we found out:

Kobo Biotech Ltd share price has depreciated -15.7% annually over the past ten years.

AVON Organics Limited (AOL) was started by P R Agarwal, Rajesh Agarwal along with late G S Sidhu .It is located at Madhupala Towers Greenlands, Hyderabad 500 016, India. The company's transition from a machinery manufacturer to a full-fledged chemical manufacturer saw the company foraying into the highly technology-intensive area of Diketene and its derivatives.

In the year 1996 the company established and successfully commissioned its first

AVON Organics Limited (AOL) was started by P R Agarwal, Rajesh Agarwal along with late G S Sidhu .It is located at Madhupala Towers Greenlands, Hyderabad 500 016, India. The company's transition from a machinery manufacturer to a full-fledged chemical manufacturer saw the company foraying into the highly technology-intensive area of Diketene and its derivatives.

In the year 1996 the company established and successfully commissioned its first grass root Diketene plant .It has doubled its production capacity by commissioning an additional 1000 TPA unit as part of its second phase in 1998.  It is an ISO 9000 certification by the Lloyds Register Quality Assurance (LRQA).

Business profile:

A keen insight and a well-planned development process saw AOL discover the opportunity in the production of Diketene - the basic unit for hundreds of derivatives in pesticides, chemicals, pharmaceuticals and dyestuffs. A highly classified technology, it has been sourced from Shanghai Peng Pu Chemical Works, China, and Xytel Technology Partnership, USA, and now rests in the hands of a few chosen manufacturers across the globe.

The company, with its immense infrastructure framework has introduced modifications to the Chinese technology and has a current production of 3000 tonnes per annum against an installed capacity of 2000 tonnes per annum. A sprawling facility of 21 acres, the plant is situated 60 kilometers from Hyderabad. The locale is ideal due to its easy connectivity made possible by the well-traversed National Highway # 9 that links Hyderabad with Mumbai.

Products :

  • Diketene:
  • Pharmaceutical intermediates
  • Agrochemical intermediates
  • Pigment intermediates 

Pharmaceutical (Including Ephedrines) :

  • Active Pharmaceutical ingredients
  • Pharma intermediates
  • Formulation intermediates 
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback